TickerFactsScreenerDevelopers

Dianthus Therapeutics, Inc. /DE/ (DNTH) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$6.53M2017: -$22.26M2018: -$41.89M2019: -$57.10M2020: -$64.02M2021: -$59.53M2022: -$29.07M2023: -$36.86M2024: -$78.18M2025: -$129.06M-$129.06M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$129.06M-65.1%
2024-$78.18M-112.1%
2023-$36.86M-26.8%
2022-$29.07M+51.2%
2021-$59.53M+7.0%
2020-$64.02M-12.1%
2019-$57.10M-36.3%
2018-$41.89M-88.1%
2017-$22.26M-241.0%
2016-$6.53M—